Previous studies have suggested that Porcupine inhibitors, including LGK974 and IWP-2, significantly inhibit the proliferation of pancreatic cancer cell lines and the tumor growth of patient-derived xenografts with inactivating RNF43 mutations11,12,31. This evidence concerns the gene RNF43 and neoplasm.